Oxytocin-pathway polygenic scores for severe mental disorders and metabolic phenotypes in the UK Biobank

Winterton, A; Bettella, F; de Lange, A-MG; Haram, M; Steen, NE; Westlye, LT; Andreassen, OA; Quintana, DS

Neuroscience & Neuroimaging Research Collection

Journal article

Oxytocin-pathway polygenic scores for severe mental disorders and metabolic phenotypes in the UK Biobank

Abstract:: AbstractOxytocin is a neuromodulator and hormone that is typically associated with social cognition and behavior. In light of its purported effects on social cognition and behavior, research has investigated its potential as a treatment for psychiatric illnesses characterized by social dysfunction, such as schizophrenia and bipolar disorder. While the results of these trials have been mixed, more recent evidence suggests that the oxytocin system is also linked with cardiometabolic conditions for which individuals with severe mental disorders are at a higher risk for developing. To investigate whether the oxytocin system has a pleiotropic effect on the etiology of severe mental illness and cardiometabolic conditions, we explored oxytocin’s role in the shared genetic liability of schizophrenia, bipolar disorder, type-2 diabetes, and several phenotypes linked with cardiovascular disease and type 2 diabetes risk using a polygenic pathway-specific approach. Analysis of a large sample with about 480,000 individuals (UK Biobank) revealed statistically significant associations across the range of phenotypes analyzed. By comparing these effects to those of polygenic scores calculated from 100 random gene sets, we also demonstrated the specificity of many of these significant results. Altogether, our results suggest that the shared effect of oxytocin-system dysfunction could help partially explain the co-occurrence of social and cardiometabolic dysfunction in severe mental illnesses.

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Winterton, A., Bettella, F., de Lange, A.-M. G., Haram, M., Steen, N. E., Westlye, L. T., Andreassen, O. A., & Quintana, D. S. (2021). Oxytocin-pathway polygenic scores for severe mental disorders and metabolic phenotypes in the UK Biobank. Translational Psychiatry, 11(1), 599–599.

MLA Style

Winterton, A, et al. “Oxytocin-Pathway Polygenic Scores for Severe Mental Disorders and Metabolic Phenotypes in the UK Biobank.” Translational Psychiatry, vol. 11, no. 1, 2021, pp. 599–99.

Chicago Style

Winterton, A, F Bettella, A-MG de Lange, et al. 2021. “Oxytocin-Pathway Polygenic Scores for Severe Mental Disorders and Metabolic Phenotypes in the UK Biobank.” Translational Psychiatry 11 (1): 599–99.
Print